Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Soy formula and allergies

This article was originally published in The Tan Sheet

Executive Summary

Babies fed soy formula do not have a lower incidence of allergies compared to those fed cow's milk formula, according to an Oct. 18 review in the Cochrane Database of Systematic Reviews. "Feeding with a soy formula cannot be recommended for prevention of allergy or food intolerance in infants at high risk of allergy or food intolerance," DA Osborn and J Sinn conclude. The authors state further research is necessary. The review examines randomized and quasi-randomized trials that compare soy formula to cow's milk. Three eligible studies enrolling 728 high risk infants with a history of allergy in the first degree relative were included. Meta-analysis found no significant difference in childhood allergy incidence (typical RR 0.73, 95% CI 0.37, 1.44), according to the review...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099903

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel